GAP Commends House of Representatives on Passage of the National Plan to End Parkinson’s Act 

The House of Representatives has passed The Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act. GAP is celebrating this exciting news and commends all who helped to make this monumental achievement possible. We are grateful for the leadership of the House in ensuring that this legislation passed, especially from U.S. […]

Read more »

GAP Applauds Johnson and Johnson’s Foray into Alzheimer’s Vaccine

We thank J&J for their leadership as they announced new efforts to combat Alzheimer’s disease, specifically their vaccine trial. In taking on this tau antibody and a tau-targeting vaccine, J&J is bringing hope to those impacted by Alzheimer’s disease, and addressing the need for cutting-edge research by launching this exciting trial. We are grateful for […]

Read more »

GAP Honors the Legacy of Sandra Day O’Connor

The Global Alzheimer’s Platform Foundation (GAP) thanks trailblazer Sandra Day O’Connor, the first female to serve as a U.S Supreme Court Justice. While she paved the way for women leaders, she also raised awareness of the challenges of caregiving when she admirably retired from the Supreme Court in 2006 to care for her husband who […]

Read more »

Georgia couple take part in clinical trials in hopes of slowing the progression of Alzheimer’s

Atlanta News First- By Sawyer Buccy Published: Nov. 29, 2023 at 4:51 PM EST|Updated: 15 hours ago ATLANTA, Ga. (Atlanta News First) – You probably know someone whose life has been impacted in one way or another by Alzheimer’s. Some people are fighting to find ways to slow the progression of the disease through clinical trials. One Georgia […]

Read more »

GAP Mourns First Lady Rosalynn Carter

The Global Alzheimer’s Platform Foundation (GAP) thanks the First Lady for the grace and dignity she showed before and after President Carter’s term, and even more so these past six months after bravely announcing her dementia diagnosis. We join many around the world mourning her loss while acknowledging her quiet, positive impact over her 96 years.  […]

Read more »

Opinion Column in Orlando Sentinel: Research funds are vital in fight against Alzheimer’s | Commentary

By JOANN GREER November 18, 2023 at 5:30 a.m. My husband and I know first-hand the toll that Alzheimer’s Disease has as we have cared for a mom and stepfather who lived with Alzheimer’s Disease before they passed away. With it being National Alzheimer’s Disease Awareness Month and National Family Caregiver’s Month, we would like to […]

Read more »

GAP Applauds New Women’s Health Research

We applaud First Lady Jill Biden and the White House Gender Policy Council on the first ever initiative on Women’s Health Research, with a focus on ‘engaging the scientific, private sector, and philanthropic communities’. GAP is committed to ensuring that clinical research includes all people, and that includes ensuring that women are equally represented. We […]

Read more »

Free health screenings for National Alzheimer’s Disease Awareness Month

POSTED ON NOVEMBER 10, 2023 by WMNF BY COLLEEN COLE More than 580,000 individuals in Florida are currently living with Alzheimer’s disease. Next Thursday, individuals 50 years and older are going to be provided free health screenings in recognition of National Alzheimer’s Disease Awareness Month at a Senior Brain Health Expo. According to a press release from […]

Read more »

GAP Congratulates New Director of National Institutes of Health (NIH)

Today, the US Senate confirmed President Biden’s nominee for National Institutes of Health (NIH) Director, Monica Bertagnolli, MD, who will lead the country’s top medical research institute. “We are thrilled that the US Senate has confirmed Dr. Monica Bertagnolli as the new Director of the NIH, as she is an esteemed leader with an impressive career […]

Read more »

Couple gets involved in Florida Alzheimer’s research trials

His wife, Joann, is a retired nurse and also knew that research was going to be the way forward for them and for future generations.   To find out about studies near you, go to K2Med.com or Fastertrials.org to find sites around the US.

Read more »

IXICO to Present Data from GAP-Sponsored First-of-its-Kind Blood-based and Digital Biomarker Platform Study at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Washington D.C., Oct 23, 2023- Global Alzheimer’s Platform Foundation, (GAP) is pleased to share that new data from the ground-breaking blood-based and digital biomarker platform study, Bio-Hermes, will be shared by study partner Dr. Robin Wolz, of IXICO, at the 16th Clinical Trials on Alzheimer’s Disease (CTAD) conference. The data will be presented at Symposium […]

Read more »

Free memory testing at Brain Matters Research in Delray Beach

‘Coming in and just answer some questions, and seeing if there’s something that needs to be investigated,’ By: Victor Jorges WPTV5 DELRAY BEACH, Fla. — A Palm Beach County research organization is helping people with their memory for free. Brain Matters Research in Delray Beach is hosting free memory screenings on Tuesday and Wednesday from 9 […]

Read more »

Memory Machine drives into town to promote brain health awareness on Oct. 6

Brain Matters Research and Neuropsychiatric Research Center of Southwest Florida take Alzheimer’s Disease clinical research on the road By Staff | Oct 4, 2023 Brain Matters Research and Neuropsychiatric Research Center of Southwest Florida will be driving clinical research into the community as they introduce the Memory Machine to Fort Myers. The new Memory Machine will allow […]

Read more »

People with Down syndrome deserve access to Alzheimer’s treatment

People with Down syndrome helped scientists pave the way for Alzheimer’s drugs but are now left out of the treatment. By Hampus Hillerstrom and Jo Ann Simons  The clinical trials for new Alzheimer’s disease treatment drugs — which researchers believe will slow the course of the disease over time — offer hope to thousands of […]

Read more »

Sarasota researchers host memory screening for Alzheimer’s

By Sydney RoellSARASOTA COUNTY,  Fla. (SNN) — In honor of Sept. 21 being World Alzheimer’s Day, a group of Sarasota researchers hosted a free bilingual memory screening. Intercoastal Medical Group Neurology and Research Clinic offered their free, confidential memory screening in English and Spanish on Thursday from 8 a.m. to 3 p.m. at Robert L. Taylor […]

Read more »

A healthy diet may lower dementia risk — even if you start late

By Janet Lee – Washington Post Consumer Reports has no financial relationship with any advertisers on this site. Doing puzzles, playing memory-boosting games, taking classes and reading are activities that we often turn to for help keeping our brains sharp. But research is showing that what you eat, how often you exercise and the type of exercise you do […]

Read more »

Sarasota researchers plan free, bilingual memory screening on World Alzheimer’s Day

Free, bilingual screening on World Alzheimer’s Day Intercoastal Medical Group Neurology and Research Clinic will hold a free, bilingual?memory?screening event on World Alzheimer’s Day on Sept. 21 from 8 a.m. to 3 p.m. at Robert L. Taylor Community Complex, 1845 John Rivers St., in Sarasota. The goal of the confidential? screening in English and Spanish […]

Read more »

How the Global Alzheimer’s Platform Foundation Contributed to AAIC

Revolutionary Studies, Record Breaking Collaboration, and Promising News on Biomarker Studies Top the Charts at AAIC   Washington D.C., Aug 31, 2023— Researchers and leaders from the Global Alzheimer’s Platform Foundation® (GAP) assembled with the world’s leading Alzheimer’s researchers, patient advocates, and clinicians at the annual Alzheimer’s Association International Conference (AAIC). From the memorable week, […]

Read more »

Aumentan los casos de Alzheimer en el Valle de Texas

Jessica Cantu from GAP-Net site El Faro Health and Therapeutics was at the Alzheimer’s Association’s International Conference (AAIC) in Amsterdam and spoke about the creation of the site in Starr County, Texas. En el condado Starr, casi uno en cada cuatro adultos de 65 años de edad en adelante fueron diagnosticados con Alzheimer en el […]

Read more »

Next On Medicare’s To Do List For Alzheimer’s: Coverage Of PET Scans And Genetic Testing

By Cathy Kelly Medicare policymakers have felt that without an effective approved treatment, coverage of amyloid PET scans and APOE4 genetic tests was not warranted. But that is changing. There is more to Medicare coverage for Alzheimer’s treatment than Leqembi, Eisai Co., Ltd. and Biogen, Inc.’s newly-approved amyloid-targeting monoclonal antibody. Now the program also is considering amending restrictive coverage […]

Read more »

Broader Medicare Coverage For Leqembi Begins As CMS-Backed Registry Opens For Business

By Cathy Kelly There is no fee to participate, and entries to the registry must be made at baseline and then every six months for up to two years. The Centers for Medicare and Medicaid Services is sticking with its plan to provide broader Medicare coverage for Eisai Co., Ltd. and Biogen, Inc.’s Leqembi for Alzheimer’s – now that […]

Read more »

Global Alzheimer’s Platform Foundation: Full FDA Approval of Leqembi Equals Hope

The FDA’s approval comes following the recommendation of an FDA advisory committee, which voted unanimously for Leqembi’s full approval earlier this month WASHINGTON, DC, July 6, 2023 — Following a decision from the U.S. Food and Drug Administration (FDA) granting full traditional approval to Leqembi, a disease-modifying Alzheimer’s treatment from Eisai, Global Alzheimer’s Platform Foundation® (GAP) […]

Read more »

The Numbers Tell The Story: Alzheimer’s Disproportionate Impact On Black Americans

GAP Community Connector, Paula Atkinson, was a guest writer for the Orlando Times and explained why she and GAP are committed to advancing Alzheimer’s clinical research in Black and Brown communities. My grandmother was treated for Alzheimer’s disease, but never diagnosed with it. Why? She was toldby her doctor that it would take too long […]

Read more »

Kerwin Medical Center seeks to slow the progression of Alzheimer’s disease

GAP-Net Site Kerwin Medical Center was featured in Community Impact on the rate of Alzheimer’s disease in Hispanic communities, and how they can help. As part of a nationwide study, Kerwin Medical Center is testing the efficacy of Aducanumab, a drug that helps a type of plaque in the brain and slows memory impairment caused […]

Read more »
To top